Clinical Trial Update: Extracorporeal Photopheresis and Low Dose Aldesleukin in Treating Patients With Steroid Refractory Chronic Graft-Versus-Host Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating extracorporeal photopheresis plus low-dose aldesleukin for steroid-refractory chronic graft-versus-host disease has completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Aldesleukin (interleukin-2)
• Extracorporeal Photopheresis

Snippet

Sponsor: City of Hope Medical Center | Conditions: Chronic Graft Versus Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2024-04-08